Literature DB >> 34532090

Disparities and survival in newly diagnosed gastric cancer in Hispanic patients in the United States: a propensity score matched analysis.

Joshua Tseng1, James P Miller1, Jeffrey Johnson1, Kevin Waters1, Alexandra Gangi1, Jun Gong1, Miguel Burch1.   

Abstract

BACKGROUND: The burden of gastric cancer involving Hispanic patients in the United States is growing as both the population and the incidence of gastric cancer in this group increases. This burden is compounded by presentation with advanced disease and socioeconomic challenges shaping cancer care. We sought to describe the demographics, socioeconomic factors, treatment, and survival experience of Hispanic patients with gastric adenocarcinoma.
METHODS: Patients with gastric adenocarcinoma diagnosed between 2004 and 2015 (n=90,737) in the National Cancer Database were retrospectively identified. Patients of Hispanic ethnicity were compared against non-Hispanic white patients. Surgical cohort was further analyzed, and 1:1 propensity score matching was used to balance covariates between Hispanic and non-Hispanic white surgical patients. Survival was compared using Kaplan-Meier method. Cox regression was used to determine prognostic factors for survival.
RESULTS: Compared to non-Hispanic white patients, Hispanic patients are more likely to be younger, female, and healthier. They were more likely to be uninsured, reside in poorer neighborhoods and reside in areas with lower rates of education. Hispanic patients were more likely to live in a metropolitan area, travel shorter distances for healthcare, and receive treatment at an academic and high volume centers. Hispanic patients were more likely to have higher stage disease presentation, higher grade tumors, lymphovascular invasion, and poorly cohesive adenocarcinoma. Hispanic patients were more likely to receive surgery, but less likely to receive adjuvant therapy. In Cox regression of all patients, unmatched surgical patients, and matched surgical patients, Hispanic ethnicity was an independent prognostic factor of improved survival.
CONCLUSIONS: Hispanic patients with gastric adenocarcinoma present with several unfavorable clinicopathologic and socioeconomic factors. Paradoxically, these patients demonstrate improved survival. Further study is warranted to characterize disease biology in this population. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Gastric cancer; Hispanic; The National Cancer Database (NCDB); ethnicity; propensity score matching

Year:  2021        PMID: 34532090      PMCID: PMC8421888          DOI: 10.21037/jgo-21-207

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  37 in total

1.  Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates.

Authors:  C P Theuer; T Kurosaki; A Ziogas; J Butler; H Anton-Culver
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

2.  Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea.

Authors:  Hyuk Yoon; Nayoung Kim; Hye Seung Lee; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Do Joong Park; Hyung Ho Kim; Hyun Chae Jung
Journal:  J Gastroenterol Hepatol       Date:  2012-05       Impact factor: 4.029

3.  Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.

Authors:  James C Yao; Jennifer F Tseng; Samidha Worah; Kenneth R Hess; Paul F Mansfield; Christopher H Crane; Isac I Schnirer; Satish Reddy; Silvia S Chiang; Azmeena Najam; Christina Yu; Geoffrey G Giacco; Keping Xie; Tsung-Teh Wu; Barry W Feig; Peter W T Pisters; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

4.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

Authors:  Ilfet Songun; Hein Putter; Elma Meershoek-Klein Kranenbarg; Mitsuru Sasako; Cornelis J H van de Velde
Journal:  Lancet Oncol       Date:  2010-04-19       Impact factor: 41.316

5.  Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity.

Authors:  R E Schwarz; K Zagala-Nevarez
Journal:  Eur J Surg Oncol       Date:  2002-04       Impact factor: 4.424

6.  Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.

Authors:  Guillaume Piessen; Mathieu Messager; Emmanuelle Leteurtre; Triboulet Jean-Pierre; Christophe Mariette
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

7.  Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion.

Authors:  Mark S Talamonti; Simon P Kim; Katherine A Yao; Jeffrey D Wayne; Joseph Feinglass; Charles L Bennett; Sambasiva Rao
Journal:  Surgery       Date:  2003-10       Impact factor: 3.982

8.  Update version of the Japanese Guidelines for Gastric Cancer Screening.

Authors:  Chisato Hamashima
Journal:  Jpn J Clin Oncol       Date:  2018-07-01       Impact factor: 3.019

Review 9.  Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?

Authors:  Gwang Ha Kim; Sung Jo Bang; Alexander R Ende; Joo Ha Hwang
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

Review 10.  Extent of lymph node dissection for adenocarcinoma of the stomach.

Authors:  Simone Mocellin; Peter McCulloch; Hussain Kazi; Joaquin J Gama-Rodrigues; Yuhong Yuan; Donato Nitti
Journal:  Cochrane Database Syst Rev       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.